Published in J Neuropathol Exp Neurol on December 01, 2003
Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx (2005) 3.41
Phagocytosis executes delayed neuronal death after focal brain ischemia. Proc Natl Acad Sci U S A (2013) 1.78
A white matter stroke model in the mouse: axonal damage, progenitor responses and MRI correlates. J Neurosci Methods (2009) 1.25
The use of animal models for stroke research: a review. Comp Med (2011) 1.07
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins. FASEB J (2006) 1.00
Neurogenesis associated with endothelin-induced cortical infarction in the mouse. Brain Res (2007) 0.96
Models that matter: white matter stroke models. Neurotherapeutics (2012) 0.93
Experimental models for analysis of oligodendrocyte pathophysiology in stroke. Exp Transl Stroke Med (2009) 0.89
Lasting pure-motor deficits after focal posterior internal capsule white-matter infarcts in rats. J Cereb Blood Flow Metab (2015) 0.88
Oligodendrogenesis in the normal and pathological central nervous system. Front Neurosci (2014) 0.87
Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther (2015) 0.87
Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum. Inflammation (2007) 0.86
The contribution of mannose binding lectin to reperfusion injury after ischemic stroke. Curr Neurovasc Res (2011) 0.86
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes. Front Aging Neurosci (2014) 0.84
A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology. J Vis Exp (2016) 0.82
CD200 restrains macrophage attack on oligodendrocyte precursors via toll-like receptor 4 downregulation. J Cereb Blood Flow Metab (2015) 0.82
Chemokines and neurodegeneration in the early stage of experimental ischemic stroke. Mediators Inflamm (2013) 0.80
Ribosomal S6 kinase regulates ischemia-induced progenitor cell proliferation in the adult mouse hippocampus. Exp Neurol (2013) 0.80
Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury. Oxid Med Cell Longev (2015) 0.78
Considerations for the Optimization of Induced White Matter Injury Preclinical Models. Front Neurol (2015) 0.78
The axon-glia unit in white matter stroke: mechanisms of damage and recovery. Brain Res (2015) 0.77
Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke. Neurosci Bull (2015) 0.75
Diabetic aggravation of stroke and animal models. Exp Neurol (2017) 0.75
Axonal protection achieved by blockade of sodium/calcium exchange in a new model of ischemia in vivo. Neuropharmacology (2012) 0.75
Neurodegeneration and Glial Response after Acute Striatal Stroke: Histological Basis for Neuroprotective Studies. Oxid Med Cell Longev (2016) 0.75
Prospects of modeling poststroke epileptogenesis. J Neurosci Res (2016) 0.75
Molecular and Cellular Responses to Interleukin-4 Treatment in a Rat Model of Transient Ischemia. J Neuropathol Exp Neurol (2016) 0.75
An Experimental Infarct Targeting the Internal Capsule: Histopathological and Ultrastructural Changes. J Pathol Transl Med (2017) 0.75
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience (1990) 4.52
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
Systemic inflammation and disease progression in Alzheimer disease. Neurology (2009) 3.79
Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest (2001) 3.72
Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience (1985) 3.27
Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur J Neurosci (1989) 3.24
Hippocampal specialization of food-storing birds. Proc Natl Acad Sci U S A (1989) 2.84
Turnover of resident microglia in the normal adult mouse brain. Neuroscience (1992) 2.73
Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge. Histopathology (1998) 2.50
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A (2000) 2.40
MR detection of brain iron. AJNR Am J Neuroradiol (1993) 2.39
Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol Appl Neurobiol (2008) 2.32
Macrophages and microglia in the nervous system. Trends Neurosci (1988) 2.32
Retinal ganglion cells that project to the dorsal lateral geniculate nucleus in the macaque monkey. Neuroscience (1984) 2.30
Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci (2003) 2.07
Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol (1998) 1.97
Assortative interactions and social networks in fish. Oecologia (2005) 1.97
Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience (1998) 1.94
The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. Anat Rec (1984) 1.91
Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience (2002) 1.90
Long-term culture of murine epidermal keratinocytes. J Invest Dermatol (2000) 1.87
The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med (1996) 1.86
Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.84
Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol (1983) 1.80
Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol (2013) 1.77
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1. Brain Behav Immun (2009) 1.76
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis. Neurology (2011) 1.75
The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med (1987) 1.75
Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science (1997) 1.70
Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci (1999) 1.68
The ganglion cell and cone distributions in the monkey's retina: implications for central magnification factors. Vision Res (1985) 1.66
The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun (2007) 1.65
Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms. Neuroscience (2008) 1.61
An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci U S A (1998) 1.61
Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol (2005) 1.59
Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci (2000) 1.59
Evidence for an amacrine cell system in the ganglion cell layer of the rat retina. Neuroscience (1981) 1.58
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A (1999) 1.53
Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med (1990) 1.52
Postnatal changes in retinal ganglion cell and optic axon populations in the pigmented rat. J Comp Neurol (1983) 1.51
Evidence for dendritic competition in the developing retina. Nature (1982) 1.50
Proinflammatory cytokines, sickness behavior, and Alzheimer disease. Neurology (2011) 1.48
Antigen markers of macrophage differentiation in murine tissues. Curr Top Microbiol Immunol (1992) 1.47
Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci (2001) 1.47
A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol (2001) 1.43
The ganglion cell layer of the retina of the rat: a Golgi study. Proc R Soc Lond B Biol Sci (1979) 1.42
CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol (1998) 1.41
The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience (1996) 1.41
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol (1997) 1.40
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol (1997) 1.39
A predicted operon map for Mycobacterium tuberculosis. Nucleic Acids Res (2007) 1.39
Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience (1996) 1.38
Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain (1997) 1.37
Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience (1996) 1.36
Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav Immun (2007) 1.34
Massive retinotectal projection in rats. Brain Res (1983) 1.32
Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol Dis (2005) 1.28
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood (2001) 1.28
The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience (1992) 1.28
Macrophage dependence of peripheral sensory nerve regeneration: possible involvement of nerve growth factor. Neuron (1991) 1.27
Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol (1987) 1.26
The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration. Neuroscience (1991) 1.24
Retinal ganglion cells that project to the superior colliculus and pretectum in the macaque monkey. Neuroscience (1984) 1.24
Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord (1998) 1.23
Cytokine-induced acute inflammation in the brain and spinal cord. J Neuropathol Exp Neurol (1999) 1.23
MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn Reson Med (2003) 1.21
Retinal ganglion cell dendritic fields in old-world monkeys are oriented radially. Brain Res (1986) 1.20
Consequences of slow Wallerian degeneration for regenerating motor and sensory axons. J Neurobiol (1992) 1.16
A mutation in the alpha 3 chain of type IX collagen causes autosomal dominant multiple epiphyseal dysplasia with mild myopathy. Proc Natl Acad Sci U S A (2000) 1.16
Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. AJNR Am J Neuroradiol (1995) 1.15
Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. Hum Pathol (1995) 1.15
Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leucocyte recruitment. Eur J Neurosci (2006) 1.15
Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr Pharm Des (2007) 1.14
Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro Oncol (2000) 1.14
Characterization of the microglial response in murine scrapie. Neuropathol Appl Neurobiol (1994) 1.12
Amacrine cells, displaced amacrine cells and interplexiform cells in the retina of the rat. Proc R Soc Lond B Biol Sci (1980) 1.12
A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc Natl Acad Sci U S A (1993) 1.12
Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol (2002) 1.12
Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS (1997) 1.11
The blood-brain barrier and the inflammatory response. Mol Med Today (1997) 1.09
Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand. Br J Pharmacol (1987) 1.09
Telomerase activity in human gliomas. Neurosurgery (1998) 1.08
Burrowing into prion disease. Neuroreport (2001) 1.07
The rate of Wallerian degeneration in cultured neurons from wild type and C57BL/WldS mice depends on time in culture and may be extended in the presence of elevated K+ levels. Eur J Neurosci (1995) 1.07
Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS). Eur J Neurosci (1995) 1.07
Using okadaic acid as a tool for the in vivo induction of hyperphosphorylated tau. Neuroscience (1998) 1.07
Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J Neurochem (2003) 1.06
Absence of detectable IL-1beta production in murine prion disease: a model of chronic neurodegeneration. J Neuropathol Exp Neurol (2001) 1.06
The topography of magnocellular projecting ganglion cells (M-ganglion cells) in the primate retina. Neuroscience (1991) 1.05
In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed (2002) 1.05
Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol (1998) 1.04
Transforming growth factor beta1, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix. Neuropathol Appl Neurobiol (2002) 1.04
Is Thy-1 expressed only by ganglion cells and their axons in the retina and optic nerve? J Neurocytol (1984) 1.04
Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med (1992) 1.04
Giant cell ependymoma of the filum terminale. A report of two cases. Am J Surg Pathol (1996) 1.04